THE PREPARATION OF MITOMYCIN-C, ADRIAMYCIN AND DAUNOMYCIN COVALENTLY BOUND TO ANTIBODIES AS IMPROVED CANCER CHEMOTHERAPEUTIC-AGENTS

被引：0
|
作者：
SUZUKI, T
SATO, E
GOTO, K
KATSURADA, Y
UNNO, K
TAKAHASHI, T
机构：
[1] AKITA UNIV HOSP, DEPT PHARM, AKITA 010, JAPAN
[2] AKITA UNIV, SCH MED, DEPT SURG, AKITA 010, JAPAN
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 1981年 / 29卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：844 / 848
页数：5
相关论文
共 50 条
  • [11] COMBINATION CHEMOTHERAPY OF GASTRIC CANCER WITH FLUORO-URACIL, ADRIAMYCIN AND MITOMYCIN-C (FAM)
    SCHEIN, PS
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1977, 3 : S29 - S29
  • [12] INDUCTION OF SISTER-CHROMATID EXCHANGES BY CHEMOTHERAPEUTIC DRUGS IN SPERMATOGONIA OF MICE - EFFECTS OF PROCARBAZINE, ADRIAMYCIN, CYCLOPHOSPHAMIDE AND MITOMYCIN-C
    ABRAHAM, SK
    FRANZ, J
    MUTATION RESEARCH, 1983, 108 (1-3): : 373 - 381
  • [13] ENDOVESICAL CHEMOTHERAPY WITH ADRIAMYCIN VERSUS ADRIAMYCIN ALTERNATED WITH MITOMYCIN-C IN THE TREATMENT OF SURFACE BLADDER-CANCER - RANDOMIZED STUDY
    BELMONTE, P
    BO, VD
    MERLO, A
    FIACCAVENTO, G
    VERONESI, A
    VOLPE, R
    CARBONE, A
    ROSSETTI, F
    FRANCINI, M
    MONFARDINI, S
    TUMORI, 1986, 72 (06) : 687 - 687
  • [14] COMBINATION CHEMOTHERAPY WITH CISPLATINUM, ADRIAMYCIN, MITOMYCIN-C (PAM) IN PATIENTS WITH ADVANCED BLADDER-CANCER
    KOSMIDIS, PA
    BACOYIANNIS, C
    HATZICHRISTOU, H
    JOURNAL OF CHEMOTHERAPY, 1990, 2 (06) : 397 - 400
  • [15] PROPHYLACTIC INTRAVESICAL INSTILLATION THERAPY WITH ADRIAMYCIN AND MITOMYCIN-C IN PATIENTS WITH SUPERFICIAL BLADDER-CANCER
    TSUSHIMA, T
    MATSUMURA, Y
    OZAKI, Y
    YOSHIMOTO, J
    OHMORI, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 : S72 - S76
  • [16] CHEMOTHERAPEUTIC TREATMENT WITH MITOMYCIN-C IN METASTATIC PROSTATE-CANCER - PHASE-II STUDY
    DELLAVALENTINA, M
    VERONESI, A
    LORE, G
    DALBO, V
    FIACCAVENTO, G
    MAGRI, MD
    FRANCINI, M
    MONFARDINI, S
    TUMORI, 1986, 72 (06) : 702 - 702
  • [17] EVALUATION OF NEW CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF MULTIPLE MYELOMA .2. MITOMYCIN-C (NSC-26980)
    BERGSAGEL, DE
    ROSS, SW
    DAVIS, P
    CANCER CHEMOTHERAPY REPORTS, 1962, (21): : 75 - 80
  • [18] ADRIAMYCIN, VINBLASTINE AND MITOMYCIN-C AS 2ND-LINE CHEMOTHERAPY IN ADVANCED BREAST-CANCER
    SULKES, A
    GEZ, E
    PFEFFER, MR
    CATANE, R
    ISACSON, R
    BIRAN, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (02) : 162 - 167
  • [19] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C IN ADVANCED COLORECTAL CANCER
    HALLER, DG
    WOOLLEY, PV
    MACDONALD, JS
    SMITH, LF
    SCHEIN, PS
    CANCER TREATMENT REPORTS, 1978, 62 (04): : 563 - 565
  • [20] EFFECT OF ADRIAMYCIN, 5-FLUOROURACIL AND MITOMYCIN-C COMBINATION CHEMOTHERAPY IN ADVANCED COLORECTAL-CANCER
    STATHOPOULOS, GP
    STERGIOU, GS
    GOLEMATIS, B
    THALASSINOS, N
    FILLIPAKIS, M
    ONCOLOGY, 1995, 52 (04) : 306 - 309
12345